دورية أكاديمية
أعرض في EDS

Analyzing the Effect of Telemedicine on Domains of Quality Through Facilitators and Barriers to Adoption: Systematic Review.

التفاصيل البيبلوغرافية
العنوان: Analyzing the Effect of Telemedicine on Domains of Quality Through Facilitators and Barriers to Adoption: Systematic Review.
المؤلفون: Kruse CS; Texas State University, San Marcos, TX, United States., Molina-Nava A; Texas State University, San Marcos, TX, United States., Kapoor Y; Texas State University, San Marcos, TX, United States., Anerobi C; Texas State University, San Marcos, TX, United States., Maddukuri H; Texas State University, San Marcos, TX, United States.
المصدر: Journal of medical Internet research [J Med Internet Res] 2023 Jan 05; Vol. 25, pp. e43601. Date of Electronic Publication: 2023 Jan 05.
نوع المنشور: Systematic Review; Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: JMIR Publications Country of Publication: Canada NLM ID: 100959882 Publication Model: Electronic Cited Medium: Internet ISSN: 1438-8871 (Electronic) Linking ISSN: 14388871 NLM ISO Abbreviation: J Med Internet Res Subsets: MEDLINE
أسماء مطبوعة: Publication: <2011- > : Toronto : JMIR Publications
Original Publication: [Pittsburgh, PA? : s.n., 1999-
مواضيع طبية MeSH: Telemedicine*/methods, Humans ; Quality of Life ; Self Efficacy ; Biometry ; Data Management ; Randomized Controlled Trials as Topic
مستخلص: Background: Telemedicine has a long history; however, its efficacy has been reported with mixed reviews. Studies have reported a wide range of quality implications when using the telemedicine modality of care.
Objective: This study aimed to analyze the effectiveness of telemedicine through 6 domains of quality through an analysis of randomized controlled trials (RCTs) published in the literature published, to date, in 2022.
Methods: A total of 4 databases were searched using a standard Boolean string. The 882,420 results were reduced to 33 for analysis through filtering and randomization. The systematic literature review was conducted in accordance with the Kruse Protocol and reported in accordance with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses; 2020).
Results: The Cohen κ statistic was calculated to show agreement between the reviewers (Cohen κ=0.90, strong). Medical outcomes associated with the telemedicine modality were 100% effective with a weighted average effect size of 0.21 (small effect). Many medical outcomes were positive but not statistically better than treatment as usual. RCTs have reported positive outcomes for physical and mental health, medical engagement, behavior change, increased quality of life, increased self-efficacy, increased social support, and reduced costs. All 6 domains of quality were identified in the RCTs and 4 were identified in 100% of the studies. Telemedicine is highly patient-centered because it meets digital preferences, is convenient, avoids stigma, and enables education at one's own pace. A few barriers exist to its wide adoption, such as staff training and cost, and it may not be the preferred modality for all.
Conclusions: The effectiveness of telemedicine is equal to or greater than that of traditional care across a wide spectrum of services studied in this systematic literature review. Providers should feel comfortable offering this modality of care as a standard option to patients where it makes sense to do so. Although barriers exist for wide adoption, the facilitators are all patient facing.
Trial Registration: PROSPERO CRD42022343478; https://www.crd.york.ac.uk/prospero/display&#95;record.php?RecordID=343478.
(©Clemens Scott Kruse, Annamaria Molina-Nava, Yajur Kapoor, Courtney Anerobi, Harshita Maddukuri. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 05.01.2023.)
References: JMIR Mhealth Uhealth. 2022 Mar 30;10(3):e30571. (PMID: 35353055)
Plast Reconstr Surg. 2010 Aug;126(2):619-625. (PMID: 20679844)
J Gen Intern Med. 2022 Apr;37(5):1198-1203. (PMID: 35091921)
Arthritis Care Res (Hoboken). 2022 Mar;74(3):484-492. (PMID: 33053261)
Breast Cancer Res Treat. 2022 Feb;191(3):553-564. (PMID: 34853988)
J Med Internet Res. 2022 May 11;24(5):e36114. (PMID: 35373776)
Clin Liver Dis (Hoboken). 2022 Apr 29;19(4):176-180. (PMID: 35505916)
Health Aff (Millwood). 2018 Dec;37(12):2014-2023. (PMID: 30633682)
BMC Prim Care. 2022 Feb 22;23(1):33. (PMID: 35193509)
J Med Internet Res. 2022 Sep 7;24(9):e36577. (PMID: 36069798)
J Med Internet Res. 2022 Jan 24;24(1):e33631. (PMID: 35072641)
Healthcare (Basel). 2020 Oct 01;8(4):. (PMID: 33019667)
Telemed J E Health. 2021 Jun;27(6):603-614. (PMID: 32976084)
Diabetes Res Clin Pract. 2022 Jul;189:109948. (PMID: 35700926)
Biochem Med (Zagreb). 2012;22(3):276-82. (PMID: 23092060)
JMIR Form Res. 2022 Mar 23;6(3):e32403. (PMID: 35138254)
J Med Internet Res. 2022 Aug 11;24(8):e37314. (PMID: 35969429)
BMC Endocr Disord. 2022 May 2;22(1):116. (PMID: 35501846)
J Gen Intern Med. 2022 Feb;37(3):521-530. (PMID: 34100234)
Nutrients. 2022 Aug 07;14(15):. (PMID: 35956410)
J Ambul Care Manage. 2012 Apr-Jun;35(2):80-9. (PMID: 22415281)
Health Aff (Millwood). 2018 Nov;37(11):1813-1820. (PMID: 30395509)
J Med Internet Res. 2018 Feb 05;20(2):e41. (PMID: 29402759)
Curr Allergy Asthma Rep. 2022 Jan;22(1):1-5. (PMID: 35061150)
BMJ. 2021 Mar 29;372:n71. (PMID: 33782057)
JAMA Netw Open. 2022 Mar 1;5(3):e224427. (PMID: 35357459)
Dig Dis Sci. 2022 Jan;67(1):93-99. (PMID: 33507442)
Am J Health Promot. 2022 Sep;36(7):1083-1093. (PMID: 35514063)
JMIR Mhealth Uhealth. 2020 Oct 23;8(10):e18426. (PMID: 33095175)
Mach Learn. 2021;110(3):451-456. (PMID: 33746357)
Eur Ann Otorhinolaryngol Head Neck Dis. 2020 Sep;137(4):257-261. (PMID: 32624390)
J Med Virol. 2022 Jan;94(1):253-262. (PMID: 34463956)
AIDS Behav. 2022 Aug;26(8):2813-2824. (PMID: 35194698)
Glob Heart. 2022 Feb 23;17(1):13. (PMID: 35342691)
JMIR Mhealth Uhealth. 2022 Mar 23;10(3):e32212. (PMID: 35319484)
Clin Cardiol. 2022 Jan;45(1):31-41. (PMID: 34952989)
J Allergy Clin Immunol Pract. 2022 Oct;10(10):2536-2542. (PMID: 35644331)
J Med Internet Res. 2022 Jan 4;24(1):e31752. (PMID: 34854815)
JMIR Mhealth Uhealth. 2022 Jul 1;10(7):e30976. (PMID: 34978535)
Pediatr Rep. 2022 Apr 12;14(2):181-189. (PMID: 35466204)
J Med Internet Res. 2022 Mar 23;24(3):e31449. (PMID: 35319478)
JMIR Mhealth Uhealth. 2022 May 16;10(5):e35867. (PMID: 35576560)
J Epidemiol Community Health. 2022 Jun;76(6):586-594. (PMID: 35277436)
PLoS Med. 2022 Apr 19;19(4):e1003966. (PMID: 35439246)
BMC Res Notes. 2022 Mar 26;15(1):119. (PMID: 35346351)
JMIR Med Inform. 2022 Feb 15;10(2):e32373. (PMID: 34978281)
J Behav Med. 2022 Feb;45(1):28-37. (PMID: 34386838)
J Med Internet Res. 2022 Mar 9;24(3):e27202. (PMID: 35262490)
JMIR Public Health Surveill. 2022 Jun 27;8(6):e33867. (PMID: 35759333)
J Med Internet Res. 2022 Jul 27;24(7):e36996. (PMID: 35896015)
JMIR Mhealth Uhealth. 2022 May 23;10(5):e34154. (PMID: 35604760)
BMC Cancer. 2022 Jul 8;22(1):747. (PMID: 35804322)
J Med Internet Res. 2022 Mar 1;24(3):e32130. (PMID: 35230245)
Healthcare (Basel). 2022 Sep 01;10(9):. (PMID: 36141283)
JMIR Public Health Surveill. 2022 Jul 14;8(7):e34277. (PMID: 35834302)
BMC Med. 2022 May 17;20(1):176. (PMID: 35578276)
Telemed J E Health. 2023 Jan;29(1):38-49. (PMID: 35613380)
JMIR Res Protoc. 2019 Oct 14;8(10):e15490. (PMID: 31527018)
J Med Internet Res. 2022 Feb 17;24(2):e25948. (PMID: 35175209)
Telemed J E Health. 2022 Sep 6;:. (PMID: 36067144)
فهرسة مساهمة: Keywords: eHealth; mHealth; mobile health; quality; telehealth; telemedicine
تواريخ الأحداث: Date Created: 20230105 Date Completed: 20230109 Latest Revision: 20230213
رمز التحديث: 20230213
مُعرف محوري في PubMed: PMC9893735
DOI: 10.2196/43601
PMID: 36602844
قاعدة البيانات: MEDLINE
الوصف
تدمد:1438-8871
DOI:10.2196/43601